testosterone enanthate has been researched along with naloxone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Carranza-Lira, S; Garza-Flores, J; Gonzalez-Castillo, A; Mendez, JP; Peres-Palacios, G; Ulloa-Aguirre, A | 1 |
| De Feo, ML; Delitala, G; Fazzi, V; Forti, G; Genazzani, AD; Maggi, M | 1 |
1 trial(s) available for testosterone enanthate and naloxone
| Article | Year |
|---|---|
Naloxone administration does not affect gonadotropin secretion in patients with Klinefelter's syndrome.
Topics: Adult; Clinical Trials as Topic; Follicle Stimulating Hormone; Humans; Infusions, Intravenous; Klinefelter Syndrome; Luteinizing Hormone; Male; Naloxone; Random Allocation; Sodium Chloride; Testosterone | 1987 |
2 other study(ies) available for testosterone enanthate and naloxone
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Changes in the responsiveness of luteinizing hormone secretion to infusion of the opioid antagonist naloxone throughout male sexual maturation.
Topics: Adolescent; Child; Ethinyl Estradiol; Humans; Luteinizing Hormone; Male; Naloxone; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Sexual Maturation; Testosterone | 1988 |